James Hackworth

Opinion author

James Hackworth, PhD, is the chief business officer at Tris Pharma. With over 15 years of multi-therapeutic area experience domestically and internationally, he has an extensive track record in licensing, M&A and partnership transactions, pharmaceutical commercialization, and drug development. Hackworth holds a PhD in physics from Columbia University and a BS degree in physics from The Ohio State University.

Negative emotion image. Person head shaped paper on black torn paper background.

Opinion

New Painkillers Critical To Fight Opioid Epidemic, Broader Pain Crisis

Alternatives to opioids are desperately needed to better treat moderate to severe acute pain, but to date, we’ve seen few novel analgesics hit the market.

February 26, 2026

6 min read

James Hackworth